semaglutide and ckd Amelia Carro — Instituto Corvilud on X: "FLOW trial stopped early due to evidence of renal protection with 📌GLP1ar show cardio-nephro-metabolic effects 📌Semaglutide has already settled its role further than antidiabetic Semaglutide in patients with overweight

8:e1352

Potential GH/IGF-1 pathway effects Because both compounds stimulate GH and IGF-1 signaling, researchers often monitor outcomes related to: Fluid retention Edema Glucose regulation Tissue growth signaling Joint discomfort or soft tissue effects Changes in IGF-1 levels CJC-1295 with DAC produced sustained GH and IGF-1 elevation in clinical studies, with no serious adverse reactions reported in the published trial, though the authors noted cumulative effects after repeated dosing. Why DAC may require extra attention Because DAC extends exposure, it may create a longer period of GH/IGF-1 signaling

A poro de 10 ml contm apenas 8 kcal, valor energtico praticamente insignificante

PiattiPMMontiLDContiMBaruffaldiLGalliLPhanCVet al